Relay Therapeutics, Inc. - RLAY

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Commodore Capital LP 5.5% 12,000,000 View
Aug 14, 2026 SCHEDULE 13G/A Commodore Capital Master LP 5.5% 12,000,000 View
Aug 14, 2026 SCHEDULE 13G/A Robert Egen Atkinson 5.5% 12,000,000 View
Aug 14, 2026 SCHEDULE 13G/A Michael Kramarz 5.5% 12,000,000 View
Aug 10, 2026 SCHEDULE 13G/A Perceptive Advisors LLC 6.4% 14,106,187 View
Aug 10, 2026 SCHEDULE 13G/A Joseph Edelman 6.4% 14,106,187 View
Aug 10, 2026 SCHEDULE 13G/A Perceptive Life Sciences Master Fund, Ltd. 6.4% 14,106,187 View
Aug 07, 2026 SCHEDULE 13G/A FMR LLC 10.0% 21,270,751 View
Aug 07, 2026 SCHEDULE 13G/A Abigail P. Johnson 10.0% 21,270,751 View
Aug 06, 2026 SCHEDULE 13G FMR LLC 9.4% 20,015,113 View
Aug 06, 2026 SCHEDULE 13G Abigail P. Johnson 9.4% 20,015,113 View
May 15, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 0.0% 0 View
May 15, 2026 SCHEDULE 13G/A Steven A. Cohen 0.0% 0 View
Apr 13, 2026 SCHEDULE 13G Perceptive Advisors LLC 9.99% 438,471 View
Apr 13, 2026 SCHEDULE 13G Joseph Edelman 9.99% 438,471 View
Apr 13, 2026 SCHEDULE 13G Perceptive Life Sciences Master Fund, Ltd. 9.99% 438,471 View
Mar 27, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.